Download Full Volume - United States Renal Data System

BPREVALENCE OF REPORTED ESRD
Reference section B
Table Table B.2 B.2 (continued)
Point prevalent rates of of reported ESRD
patients
patients
alive
alive
on
on
December
December
31
31
of
of
each
each
year,
year,
per
per
million
million
population,
population,
by
by
demographic
demographic
characteristics
characteristics
&
&
primary
primary
diagnosis
diagnosis
326
ADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
0-4 20.5 20.1 20.2 21.6 20.3 21.2 22.4 24.5 24.2 23.4 22.6
5-9 38.7 39.4 39.7 39.7 42.5 41.3 42.0 41.9 44.1 45.8 47.4
10-14 69.4 73.2 76.0 77.8 76.6 80.2 80.2 82.7 82.5 85.9 83.8
15-19 140.9 143.2 146.6 146.8 148.9 149.2 153.5 155.0 158.5 160.0 165.8
20-29 373.3 385.3 392.9 401.9 406.8 413.1 414.5 414.8 412.8 405.3 399.0
30-39 763.2 797.1 820.7 846.0 868.0 892.1 916.4 936.4 950.4 966.7 981.2
40-49 1,292.4 1,357.0 1,414.5 1,467.1 1,507.8 1,555.3 1,587.0 1,621.1 1,643.3 1,665.8 1,686.7
50-59 2,060.0 2,203.4 2,308.0 2,408.5 2,503.8 2,617.4 2,720.4 2,790.7 2,879.6 2,937.4 2,991.6
60-64 2,739.8 2,960.3 3,169.9 3,374.2 3,544.1 3,717.8 3,837.7 3,973.3 4,077.8 4,202.4 4,321.8
65-69 3,123.9 3,375.2 3,552.4 3,798.4 4,033.8 4,280.3 4,541.1 4,685.1 4,870.1 5,002.1 5,129.3
70-79 3,115.5 3,463.5 3,720.9 4,003.0 4,296.5 4,547.6 4,754.1 4,954.9 5,102.9 5,326.0 5,469.4
80+ 2,063.6 2,284.7 2,475.5 2,722.3 2,948.1 3,203.7 3,431.4 3,664.6 3,813.1 4,021.7 4,193.1
0-19 67.4 69.0 70.6 71.5 72.1 73.0 74.5 76.0 77.3 78.8 79.9
20-44 682.6 708.9 731.6 752.1 769.4 788.7 804.7 816.6 826.1 832.9 841.2
45-64 2,076.1 2,225.3 2,346.1 2,465.2 2,567.4 2,682.6 2,772.7 2,854.1 2,929.8 2,997.1 3,058.3
65-74 3,194.3 3,490.9 3,700.1 3,956.4 4,210.7 4,432.4 4,638.1 4,807.3 4,984.0 5,164.3 5,312.9
75+ 2,364.5 2,629.9 2,848.3 3,112.0 3,367.2 3,639.3 3,878.7 4,103.2 4,244.7 4,456.3 4,609.5
Male 1,180.0 1,262.6 1,326.6 1,400.2 1,469.5 1,540.3 1,604.8 1,662.1 1,711.2 1,763.9 1,805.6
Female 848.8 909.3 957.4 1,006.0 1,048.0 1,093.2 1,131.8 1,165.7 1,193.4 1,218.4 1,242.1
White 715.8 764.4 801.7 844.9 885.6 926.5 967.1 1,006.7 1,038.3 1,068.9 1,095.6
Black 3,216.1 3,454.6 3,645.6 3,838.1 4,017.1 4,200.4 4,323.6 4,430.1 4,518.1 4,622.9 4,712.3
Native American 2,076.9 2,210.9 2,335.8 2,416.1 2,482.8 2,598.7 2,672.0 2,575.9 2,608.4 2,601.6 2,573.5
Asian 1,104.1 1,224.5 1,317.8 1,386.3 1,439.6 1,504.4 1,559.5 1,587.1 1,616.6 1,654.0 1,671.4
†Hispanic 1,592.2 1,693.5 1,791.1 1,888.0 1,957.3 2,018.9 2,079.6 2,129.0
†Non-Hispanic 1,144.6 1,198.6 1,254.8 1,304.5 1,350.3 1,387.6 1,425.3 1,457.6
Diabetes 292.5 324.1 354.4 386.7 417.4 445.6 469.0 492.6 512.0 529.8 543.2
Hypertension 271.5 291.2 296.9 305.7 314.0 323.7 333.4 340.9 348.0 356.4 364.8
Glomerulonephritis 195.2 204.8 212.2 219.7 225.7 232.0 236.8 239.8 242.5 245.2 246.6
Cystic kidney 50.9 53.3 55.4 56.8 58.2 60.2 62.2 63.8 65.2 66.6 67.9
Other urologic 28.9 29.8 32.5 35.1 37.3 39.2 41.5 42.9 43.9 45.2 46.1
Other cause 104.8 109.9 116.6 122.1 126.9 133.1 137.9 142.8 146.3 150.2 154.1
Unknown cause 45.7 47.7 48.3 49.8 50.9 52.4 54.4 56.2 57.9 59.4 61.0
Missing disease 10.8 9.9 9.8 9.7 9.6 9.8 10.4 11.0 11.4 11.9 12.6
All 1,000.3 1,070.8 1,126.1 1,185.5 1,240.1 1,296.1 1,345.7 1,390.0 1,427.2 1,464.5 1,496.2
Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity
are adjusted for gender & age, rates by primary diagnosis are adusted for age, gender, & race.
The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.
Age is calculated as of December 31.
U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.
*Values for cells with 10 or fewer patients are suppressed.
†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.